Skip to Content
Merck
  • An advantageous route to oxcarbazepine (trileptal) based on palladium-catalyzed arylations free of transmetallating agents.

An advantageous route to oxcarbazepine (trileptal) based on palladium-catalyzed arylations free of transmetallating agents.

Organic letters (2005-10-21)
Mónica Carril, Raul SanMartin, Fátima Churruca, Imanol Tellitu, Esther Domínguez
ABSTRACT

[reaction: see text] A new route to oxcarbazepine (Trileptal), the most widely prescribed antiepileptic drug, starting from commercially available 2'-aminoacetophenone and 1,2-dibromobenzene, is reported. The sequentially accomplished key steps are palladium-catalyzed intermolecular alpha-arylation of ketone enolates and intramolecular N-arylation reactions. After several experiments to establish the best conditions for both arylation processes, the target oxcarbazepine is obtained in a satisfactory overall yield, minimizing the number of steps and employing scalable catalytic procedures developed in partially aqueous media.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
1,2-Dibromobenzene, 98%
Sigma-Aldrich
2′-Aminoacetophenone, ≥98%
Sigma-Aldrich
2′-Aminoacetophenone, 98%